All Pharma News
MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting

MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting
BUSINESSWIRE
04 Apr 2024
Share Share
Japanese pharma firm Eli Lilly, Nippon Shinyaku join hands haematologic oncology

Japanese pharma firm Eli Lilly, Nippon Shinyaku join hands haematologic oncology
BIOSPECTRUM ASIA
28 Mar 2024
Share Share
The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN

The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN
BUSINESSWIRE
30 Aug 2023
Share Share
Japan approves iron deficiency drug from Pharmacosmos

Japan approves iron deficiency drug from Pharmacosmos
M.A. Hemmingsen MEDWATCH
29 Mar 2022
Share Share
Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China

Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China
PRESS RELEASE
26 Jan 2022
Share Share
Capricor Tx, Nippon Shinyaku Partner for CAP-1002 in DMD

Capricor Tx, Nippon Shinyaku Partner for CAP-1002 in DMD
GLOBENEWSWIRE
25 Jan 2022
Share Share
Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan

Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan
PHARMABIZ
11 Nov 2021
Share Share
Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement

Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement
PRNEWSWIRE
29 Mar 2021
Share Share
Nippon Shinyaku’s DMD Drug Gets Orphan Status in Europe

Nippon Shinyaku’s DMD Drug Gets Orphan Status in Europe
JIHO
09 Jun 2020
Share Share
Nippon Shinyaku inks new agreement for prostate cancer treatment

Nippon Shinyaku inks new agreement for prostate cancer treatment
BIOSPECTRUMASIA
12 Feb 2020
Share Share